Abstract:CONTEXT: As a glucocorticoid drug, dexamethasone has good therapeutic effects for ulcerative colitis. pH-sensitive hydrogels could make conventional changes of volume in response with different pH values. Meanwhile, they could load drugs depending on its internal three-dimensional network structure.OBJECTIVE: Appropriate methods were used to improve the drug-loading capacity of hydrogel and exploring the colon-targeting character of dexamethasone hydrogel.MATERIALS AND METHODS: Different solvents (ethanol and 1,2-propanediol) were employed to dissolve dexamethasone as well as hydrogel monomer materials (poly(ethylene glycol) methyl ether (MPEG)-poly(lactide acid)-acryloyl chloride macromonomer, itaconic acid (IA) and MPEG-methacrylate), then mixing them together to prepare hydrogel through the heat-initiated free radical polymerization method. Differential scanning calorimetry and X-ray diffraction methods were used to verify whether dexamethasone was loaded into hydrogels. In vitro drug release behavior and in vivo pharmacokinetic study were also investigated in detail.RESULTS: Dexamethasone was successfully loaded into hydrogel, and its loading capacity was improved (5 mg/g). Both the in vitro release study and the in vivo pharmacokinetic study showed the good colon-targeting character of the pH-sensitive P(LE-IA-MEG) hydrogel (T max = 1.0 h, C max = 2.16 µg/ml of dexamethasone; T max = 3.9 h, C max = 0.43 µg/ml of dexamethasone hydrogel).DISCUSSION: Dexamethasone could be targeted to the colon site by P(LE-IA-MEG) hydrogel, thereby improving its therapeutic effect and reduce its side effects.CONCLUSION: P(LE-IA-MEG) hydrogel might have great potential application in colon-targeted drug delivery systems.

Synthesis and Delivery Characteristics of Colon-Specific Dexamethasone Prodrug

Synthesis of an Enzyme—dependent Prodrug and Evaluation of Its Potential for Colon Targeting

[Pharmacokinetics of Site-Specific Delivery of Dexamethasone-Dextran Prodrug in Rat Gastrointestinal Tract].

[Characteristics of Drug-Release in Vitro of Different Dextran-Dexamethasone Conjugates].

SYNTHESIS AND IN VITRO BIODEGRADATION OF AZO POLYMER FOR COLON-SPECIFIC DRUG DELIVERY

Delivery of Glucocorticoid Conjugate in Rat Gastrointestinal Tract and Its Treatment for Ulcerative Colitis.

Synthesis and Characterization of Azo-Containing Dextran Hydrogels as Carriers for Colonic Drug Targeting

Design of colon-targeted drug delivery of dexamethasone: Formulation and in vitro characterization of solid dispersions

Enhanced Percutaneous Delivery of Methotrexate Using Micelles Prepared with Novel Cationic Amphipathic Material

Assessment of the drug loading, in vitro and in vivo release behavior of novel pH-sensitive hydrogel

Preparation of budesonide–dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis

In Vitro and in Vivo Evaluation of a Novel Capsule for Colon-Specific Drug Delivery.

Synthesis and Antitumor Activity of Stearate-G-dextran Micelles for Intracellular Doxorubicin Delivery.

Enhanced Ocular Drug Delivery of Dexamethasone Using a Chitosan-Coated Soluplus®-Based Mixed Micellar System

Enzyme‐based Hydrogels Containing Dextran As Drug Delivery Carriers: Preparation, Characterization, and Protein Release

Esterification of Salicylic acid with Succinylated Dextran Using ZrOCl2.8H2O over MCM-41: A Novel Strategy to Design Polysaccharide-Based Macromolecular Prodrugs

Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy

Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors

Preparation and drug delivery of dextran-drug complex

A stable, sensitive assay for human fibronectin.

[Hematuria in children].